Table of Contents

Executive Summary

Back to Pharmaceuticals Reports Index and Shopping Cart

Back to Process Equipment Reports Index and Shopping Cart

Back To REPORTFINDER home page and Search Engine

TABLE OF CONTENTS

EXECUTIVE SUMMARY

INTRODUCTION

Definitions

Methodology

The UK Economy

Overview

Political Climate

Interest Rates

Inflation

Exchange Rates

Taxation

Consumer Demand

Output

Investment

Forecasts

Abbreviations

PHARMACEUTICAL MARKET OVERVIEW

Market Size and Trends, 1993-1997

Market Segmentation

Prescribed Pharmaceutical Market

OTC Pharmaceutical Market

Factors Affecting Demand

Market Forecasts, 1998-2002

MARKET SIZE

Market Overview, 1993-1997

Market Segmentation

Overview

Primary Manufacturing Plant

Secondary Manufacturing Plant

Factors Affecting Demand

Market Forecasts, 1998-2002

CRITICAL SUCCESS FACTORS

OPPORTUNITIES FOR SUPPLIERS

INDUSTRY STRUCTURE

Overview

Company Profiles

Aeromatic-Fielder

BWI

GEI International

Glatt Protech

T Giusti

Hosokawa Micron

Pall Europe

Romaco UK

Sussex & Berkshire Machinery

TRADE ASSOCIATIONS

MAGAZINES

List of Tables

1 Economic Indicators On The UK Economy, 1989-1998

2 The UK Pharmaceutical Market, 1993-1997

3 UK Pharmaceutical Market, By Sector, 1993-1997

4 UK Prescribed Pharmaceutical Market, 1993-1997

5 UK Pharmaceutical Sales To The NHS, By Type, 1993-1997

6 NHS Prescriptions Dispensed In The UK By Chemists And Appliance Contractors, 1987-1997

7 NHS Prescriptions Dispensed In England, By Drug Form, 1993-1997

8 UK OTC Pharmaceutical Sales, 1993-1997

9 Forecast Population in England And Wales, By Age Group, 1994-2031

10 Forecast UK Pharmaceutical Market, 1998-2002

11 UK Market For Manufacturing Plant And Machinery Used In Pharmaceutical Production, 1993-1997

12 UK Market For Manufacturing Plant And Machinery Used In Pharmaceutical Production, By Sector, 1993-1997

13 UK Market For Primary Manufacturing Plant And Machinery Used In Pharmaceutical Production, 1993-1997

14 UK Market For Primary Manufacturing Plant And Machinery Used In Pharmaceutical Production, By Type, 1993-1997

15 UK Market For Secondary Manufacturing Plant And Machinery Used In Pharmaceutical Production, 1993-1997

16 UK Market For Secondary Manufacturing Plant And Machinery Used In Pharmaceutical Production, By Type, 1993-1997

17 Forecast UK Market For Manufacturing Plant And Machinery Used In Pharmaceutical Production, 1998-2002

18 Forecast UK Market For Manufacturing Plant And Machinery Used In Pharmaceutical Production, By Sector, 1998-2002

19 Forecast UK Market For Primary Manufacturing Plant And Machinery Used In Pharmaceutical Production, By Type, 1998-2002

20 Forecast UK Market For Secondary Manufacturing Plant And Machinery Used In Pharmaceutical Production, By Type, 1998-2002

21 Financial Summary Of Aeromatic-Fielder, 1992-1996

22 Financial Summary Of BWI, 1992-1996

23 Turnover Of BWI, By Division, 1995 And 1996

24 Turnover Of BWI, By Geographical Destination, 1995 And 1996

25 Financial Summary Of GEI Processing, 1993-1997

26 Turnover Of GEI International, By Geographical Origin, 1996 And 1997

27 Financial Summary Of T Giusti, 1992-1996

28 Turnover Of T Giusti, By Geographical Area, 1995 And 1996

29 Financial Summary Of Hosokawa Micron, 1992-1996

30 Financial Summary Of Pall Europe, 1992-1996

31 Turnover Of Pall Europe, By Geographical Destination, 1995 And 1996

32 Financial Summary Of Romaco UK, 1991-1995

33 Turnover Of Romaco UK, By Geographical Market, 1994 And 1995

34 Financial Summary Of Sussex & Berkshire Machinery, 1992-1996

Back to Top

EXECUTIVE SUMMARY

Although the UK market for pharmaceutical manufacturing plant has increased during the mid 1990s, the increases have been relatively small. Indeed, once the effects of inflation have been taken into account the market has declined slightly in real terms during the review period. MSI project that the UK pharmaceutical manufacturing plant market will reach £519.9 million at 1996 msp in 1997.

There are a number of reasons why demand for pharmaceutical manufacturing plant has been constrained during the review period, including the restructuring of the global pharmaceutical manufacturing industry which has resulted in excess UK production capacity. Moreover, many pharmaceutical manufacturers are locating production sites in lower production cost countries and nearer to end user markets. This has resulted in increased investment in other countries, notably Pacific Rim countries, and reduced investment in the UK.

Secondary manufacturing plant continues to account for the majority of the pharmaceutical manufacturing plant and machinery, accounting for some 66 percent of the market in 1997. Indeed the proportional importance of secondary manufacturing equipment has increased during the review period.

The relatively static market for pharmaceutical manufacturing plant, in real terms, is in contrast to the continuing expansion of the UK pharmaceutical market which increased in value by 42 percent during the period 1993 to 1997.

MSI forecast that the UK market for pharmaceutical manufacturing plant will increase during the period 1998 to 2002. The most significant increases are expected to be towards the end of the forecast period as the excess capacity at the time of writing is no longer prevalent and investment in the UK increases.

A significant proportion of the equipment used in pharmaceutical manufacture in the UK is imported, particularly from manufacturers in other European countries. The strength of Sterling during 1997 has further increased the competitiveness of imported machinery into the UK.

In addition to activity in the pharmaceutical industry there are also a number of other factors which affect the market for pharmaceutical manufacturing plant. One of the most important changes in recent years was the introduction of patient packs which significantly increased demand for packaging machinery.

Although the overall UK market for pharmaceutical manufacturing plant has not increased significantly, some sectors of the market have been more buoyant, such as storage tanks and packaging equipment.

A further factor which has constrained the value of the market is the buoyant trade in refurbished equipment, particularly in the primary process plant sector.

Text © 1997 MSI

Back to Top

Back To REPORTFINDER HOME PAGE

Ariadne - working together with our customers to enhance productivity and increase knowledge

© 1999 www.the-list.co.uk Ariadne

Last updated by Duncan Nottage 5th March 1999